Apellis Pharmaceuticals (APLS) Income Statement (2016 - 2026)
Income Statement report data from Sep 30, 2016 to Mar 31, 2026 for Apellis Pharmaceuticals (APLS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Sep 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||||||||||||||
Total Revenue | 268M (+34.21%) | 200M (-56.41%) | 459M (+156.92%) | 178M (+7.01%) | 167M (-21.52%) | 213M (+7.98%) | 197M (-1.43%) | 200M (+15.88%) | 172M (+17.73%) | 146M (+32.59%) | 110M (+16.25%) | 95M (+111.75%) | 45M (+97.93%) | 23M (+2.72%) | 22M (+35.17%) | 16M (+13.49%) | 14M (-76.15%) | 60M (+967.08%) | 5.65M (+811.29%) | 620K | - | 250M (+38361.54%) | 650K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||||||||||||||
Research And Development | 77M (+3.68%) | 74M (+8.86%) | 68M (+1.75%) | 67M (-22.45%) | 86M (+13.19%) | 76M (-13.80%) | 89M (+13.62%) | 78M (-7.97%) | 85M (+22.26%) | 69M (-12.77%) | 79M (-16.98%) | 96M (-13.06%) | 110M (+10.67%) | 99M (+4.42%) | 95M (-6.34%) | 102M (+11.78%) | 91M (+16.33%) | 78M (-10.89%) | 88M (-8.56%) | 96M (+14.20%) | 84M (+66.89%) | 50M (-45.99%) | 93M (+7.03%) | 87M (+25.71%) | 69M (-11.71%) | 78M (+52.90%) | 51M (+1.22%) | 51M (+25.25%) | 40M (+31.39%) | 31M (+4.30%) | 30M (+7.26%) | 28M (+58.28%) | 17M (+32.52%) | 13M (+37.92%) | 9.52M (-8.64%) | 10M (+44.12%) | 7.23M (+16.05%) | 6.23M |
Selling General And Administrative | 124M (-15.49%) | 147M (+3.10%) | 143M (+8.80%) | 131M (+1.38%) | 129M (+6.48%) | 121M (-0.41%) | 122M (-4.76%) | 128M (-1.10%) | 130M (-8.60%) | 142M (-2.71%) | 146M (+30.78%) | 111M (+9.09%) | 102M (+21.00%) | 84M (+7.60%) | 78M (+24.07%) | 63M (+23.46%) | 51M (+23.47%) | 41M (-9.40%) | 46M (-6.56%) | 49M (+20.68%) | 41M (-8.79%) | 44M (+20.28%) | 37M (+30.20%) | 28M (-3.69%) | 30M (+7.39%) | 27M (+47.45%) | 19M (+45.77%) | 13M (+56.43%) | 8.17M (+27.86%) | 6.39M (+1.91%) | 6.27M (+5.38%) | 5.95M (+47.28%) | 4.04M (-16.87%) | 4.86M (+134.78%) | 2.07M (+21.05%) | 1.71M (-6.04%) | 1.82M (+82.00%) | 1.00M |
Operating Expenses | 242M (-3.68%) | 251M (+6.65%) | 235M (+11.15%) | 212M (-15.33%) | 250M (+4.79%) | 239M (-2.22%) | 244M (+6.54%) | 229M (-2.26%) | 234M (+1.53%) | 231M (-6.70%) | 247M (+14.89%) | 215M (-2.06%) | 220M (+17.79%) | 187M (+6.70%) | 175M (+6.09%) | 165M (+15.04%) | 143M (-4.22%) | 150M (+12.00%) | 134M (-31.43%) | 195M (+56.44%) | 125M (+3.93%) | 120M (-7.93%) | 130M (+12.72%) | 116M (+16.92%) | 99M (-6.75%) | 106M (+51.45%) | 70M (+10.19%) | 63M (+30.48%) | 49M (+30.78%) | 37M (+3.91%) | 36M (+6.90%) | 33M (+56.20%) | 21M (+19.18%) | 18M (+55.22%) | 12M (-4.45%) | 12M (+34.03%) | 9.05M (+25.17%) | 7.23M |
Depreciation And Amortization | 290K (-73.87%) | 1.11M | - | - | 450K (-66.67%) | 1.35M | - | - | 440K (-67.65%) | 1.36M | - | - | 420K (-64.41%) | 1.18M | - | - | 380K (-65.45%) | 1.10M | - | - | 280K (-49.09%) | 550K | - | - | 90K (-55.00%) | 200K | - | - | 40K | - | - | - | - | - | - | - | - | - |
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Income | 26M | -51.14M | 223M | -33.29M (-60.05%) | -83.33M (+218.42%) | -26.17M (-44.65%) | -47.28M (+60.60%) | -29.44M (-52.58%) | -62.09M (-26.54%) | -84.52M (-38.34%) | -137.08M (+13.82%) | -120.44M (-31.21%) | -175.08M (+6.72%) | -164.05M (+7.26%) | -152.94M (+2.91%) | -148.62M (+15.21%) | -129.00M (+44.30%) | -89.40M (-30.15%) | -127.99M (-34.12%) | -194.29M (+55.94%) | -124.59M | 130M | -129.55M (+12.15%) | -115.51M (+16.92%) | -98.79M (-6.75%) | -105.94M (+51.45%) | -69.95M (+10.19%) | -63.48M (+30.48%) | -48.65M (+30.78%) | -37.20M (+3.91%) | -35.80M (+6.90%) | -33.49M (+56.20%) | -21.44M (+19.18%) | -17.99M (+55.22%) | -11.59M (-4.45%) | -12.13M (+34.03%) | -9.05M (+25.17%) | -7.23M |
Ebit | 26M | -51.14M | 223M | -33.29M (-60.05%) | -83.33M (+218.42%) | -26.17M (-44.65%) | -47.28M (+60.60%) | -29.44M (-52.58%) | -62.09M (-26.54%) | -84.52M (-38.34%) | -137.08M (+13.82%) | -120.44M (-31.21%) | -175.08M (+6.72%) | -164.05M (+7.26%) | -152.94M (+2.91%) | -148.62M (+15.21%) | -129.00M (+44.30%) | -89.40M (-30.15%) | -127.99M (-34.12%) | -194.29M (+55.94%) | -124.59M | 130M | -129.55M (+12.15%) | -115.51M (+16.92%) | -98.79M (-6.75%) | -105.94M (+51.45%) | -69.95M (+10.19%) | -63.48M (+30.48%) | -48.65M (+30.78%) | -37.20M (+3.91%) | -35.80M (+6.90%) | -33.49M (+56.20%) | -21.44M (+19.18%) | -17.99M (+55.22%) | -11.59M (-4.45%) | -12.13M (+34.03%) | -9.05M (+25.17%) | -7.23M |
EBITDA | 27M | -57.20M | 228M | -30.53M (-63.16%) | -82.88M (+185.50%) | -29.03M (-34.50%) | -44.32M (+57.27%) | -28.18M (-54.29%) | -61.65M (-23.53%) | -80.62M (-42.05%) | -139.11M (+15.01%) | -120.95M (-30.75%) | -174.66M (+44.18%) | -121.14M (-36.12%) | -189.64M (+23.41%) | -153.67M (+19.48%) | -128.62M | 4.17M | -195.57M (-10.78%) | -219.19M (+76.33%) | -124.31M | 140M | -135.70M (+14.40%) | -118.62M (+20.18%) | -98.70M (+0.46%) | -98.25M (+40.72%) | -69.82M (-1.79%) | -71.09M (+46.25%) | -48.61M (+33.32%) | -36.46M (+1.36%) | -35.97M (+7.92%) | -33.33M (+53.31%) | -21.74M (+19.06%) | -18.26M (+57.82%) | -11.57M (-4.62%) | -12.13M (+34.03%) | -9.05M (+25.52%) | -7.21M |
Other Income / Expenses | ||||||||||||||||||||||||||||||||||||||
Interest Expense | 10M (-4.88%) | 11M (-3.81%) | 11M (+1.17%) | 11M (+0.90%) | 11M (-4.16%) | 12M (-7.98%) | 13M (+33.87%) | 9.36M (+34.29%) | 6.97M (-74.92%) | 28M (+2987.78%) | 900K (0.00%) | 900K | - | 2.70M (+126.89%) | 1.19M (-34.97%) | 1.83M | - | 12M | - | - | - | 3.58M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 90K | -130.00K | 40K (-73.33%) | 150K | -160.00K (-92.63%) | -2.17M | 70K (+250.00%) | 20K | -500.00K (-31.51%) | -730.00K (+21.67%) | -600.00K (+900.00%) | -60.00K (-78.57%) | -280.00K (-3.45%) | -290.00K | 100K (-33.33%) | 150K | -290.00K | 1.36M | -120.00K (+100.00%) | -60.00K | 1.54M | -500.00K (+2400.00%) | -20.00K | 10K (0.00%) | 10K | -170.00K (+183.33%) | -60.00K | 230K | -250.00K (+1150.00%) | -20.00K (0.00%) | -20.00K (-33.33%) | -30.00K (0.00%) | -30.00K (-78.57%) | -140.00K | - | - | - | 20K |
Net Income | ||||||||||||||||||||||||||||||||||||||
Income Before Tax | 19M | -58.64M | 216M | -41.68M (-54.64%) | -91.88M (+154.73%) | -36.07M (-36.55%) | -56.85M (+51.44%) | -37.54M (-43.34%) | -66.25M (-23.98%) | -87.15M (-37.75%) | -140.00M (+14.90%) | -121.84M (-31.36%) | -177.50M (+6.00%) | -167.46M (-12.24%) | -190.82M (+22.72%) | -155.49M (+12.89%) | -137.73M (-6.67%) | -147.58M (-24.54%) | -195.57M (-10.78%) | -219.19M (+19.35%) | -183.66M (-46.46%) | -343.03M | - | - | - | -304.71M | - | - | - | -127.50M | - | - | - | - | - | - | - | - |
Income Tax Expense | 500K (+61.29%) | 310K (-48.33%) | 600K (+27.66%) | 470K (+38.24%) | 340K (+17.24%) | 290K (-50.85%) | 590K (+436.36%) | 110K (-35.29%) | 170K (-88.03%) | 1.42M (+517.39%) | 230K (+21.05%) | 190K (-32.14%) | 280K | -1.47M | 450K (-8.16%) | 490K (-59.50%) | 1.21M (+245.71%) | 350K | - | - | - | 1.85M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | 19M | -58.95M | 216M | -42.15M (-54.29%) | -92.22M (+153.70%) | -36.35M (-36.72%) | -57.44M (+52.52%) | -37.66M (-43.30%) | -66.42M (-25.02%) | -88.58M (-36.84%) | -140.24M (+14.91%) | -122.04M (-31.35%) | -177.78M (+7.10%) | -165.99M (-13.22%) | -191.27M (+22.62%) | -155.98M (+12.27%) | -138.93M (-6.08%) | -147.93M (-24.36%) | -195.57M (-10.78%) | -219.19M (+19.35%) | -183.66M | 78M | -135.70M (+14.40%) | -118.62M (-29.74%) | -168.82M (+49.11%) | -113.22M (+62.16%) | -69.82M (-1.79%) | -71.09M (+40.58%) | -50.57M (+38.70%) | -36.46M (+1.36%) | -35.97M (+7.92%) | -33.33M (+53.31%) | -21.74M (+19.06%) | -18.26M (+57.82%) | -11.57M (-4.62%) | -12.13M (+34.03%) | -9.05M (+25.52%) | -7.21M |
Net Income | 19M | -58.95M | 216M | -42.15M (-54.29%) | -92.22M (+153.70%) | -36.35M (-36.72%) | -57.44M (+52.52%) | -37.66M (-43.30%) | -66.42M (-25.02%) | -88.58M (-36.84%) | -140.24M (+14.91%) | -122.04M (-31.35%) | -177.78M (+7.10%) | -165.99M (-13.22%) | -191.27M (+22.62%) | -155.98M (+12.27%) | -138.93M (-6.08%) | -147.93M (-24.36%) | -195.57M (-10.78%) | -219.19M (+19.35%) | -183.66M | 78M | -135.70M (+14.40%) | -118.62M (-29.74%) | -168.82M (+49.11%) | -113.22M (+62.16%) | -69.82M (-1.79%) | -71.09M (+40.58%) | -50.57M (+38.70%) | -36.46M (+1.36%) | -35.97M (+7.92%) | -33.33M (+53.31%) | -21.74M (+19.06%) | -18.26M (+57.82%) | -11.57M (-4.62%) | -12.13M (+34.03%) | -9.05M (+25.52%) | -7.21M |
Comprehensive Income Net Of Tax | 18M (-22.21%) | 24M (-89.07%) | 216M | -41.67M (-54.69%) | -91.97M (-53.47%) | -197.64M (+245.40%) | -57.22M (+52.63%) | -37.49M (-43.55%) | -66.41M (-87.50%) | -531.29M (+278.12%) | -140.51M (+15.12%) | -122.06M (-31.30%) | -177.68M (-72.70%) | -650.96M (+240.64%) | -191.10M (+21.63%) | -157.11M (+13.11%) | -138.90M (-81.44%) | -748.33M (+282.29%) | -195.75M (-10.78%) | -219.40M (+18.49%) | -185.16M (-46.31%) | -344.84M (+150.26%) | -137.79M (+15.50%) | -119.30M (-28.84%) | -167.66M (-44.98%) | -304.74M (+335.90%) | -69.91M (-1.66%) | -71.09M (+40.58%) | -50.57M (-60.37%) | -127.62M (+258.18%) | -35.63M (+6.90%) | -33.33M (+53.31%) | -21.74M (-57.38%) | -51.01M (+340.88%) | -11.57M | - | - | - |